Filling the Information Void: Using Public Registries as a Tool in Nanotechnologies Regulation
- 71 Downloads
Based on the experiences of two high profile voluntary data collection programs for engineered nanomaterials, this article considers the merit of an international online registry for scientific data on engineered nanomaterials and environmental, health and safety (EHS) data. Drawing on the earlier experiences from the pharmaceutical industry, the article considers whether a registry of nanomaterials at the international level is practical or indeed desirable, and if so, whether such an initiative—based on the current state of play—should be voluntary or mandatory. The article commences with an examination of the success and failures of voluntary reporting schemes in the UK and the US, as well as the International Council of Nanotechnology’s EHS Database and the OECD’s Working Party on Manufactured Nanomaterials. The article then examines the history of clinical trials registries, including the key motivations behind their creation, the role of self-regulation, and the perceived benefits thereof. Key lessons of the rise of clinical trials registration are highlighted, as are crucial considerations that must be addressed by policy makers should a multi-lateral public registry for data on nanoscale materials and EHS research be perceived to be a desirable option. The article concludes by arguing that while the creation of a registry to record information generated on nanomaterials is not straightforward, this reason alone should not deter industry from taking a proactive approach to the dissemination of fundamental data and research findings.
KeywordsNanotechnologies Regulation Registries Transparency Public health and safety
- BASF. 2004. Code of conduct for nanotechnology. Ludwigshafen: BASF.Google Scholar
- BASF. 2006. In dialogue: Nanotechnology at BASF. Ludwigshafen: BASF.Google Scholar
- Coalition of Non-Governmental Organizations. 2007. Principles for the oversight of nanotechnologies and nanomaterials, 31 July. http://www.foeeurope.org/activities/nanotechnology/Documents/Principles_Oversight_Nano.pdf (accessed October 7, 2007).
- Davies, S. 2008. Letter: Nano-enabled choice. The Guardian, 29 March. http://www.guardian.co.uk/science/2008/mar/29/nanotechnology (accessed June 5, 2008).
- Denison, R. 2007. Statement of Richard A. Denison, Ph.D., Senior Scientist USEPA’s Public Meeting on the Development of a Voluntary Nanoscale Materials Stewardship Program, 2 August. Washington DC: Environmental Defense.Google Scholar
- Department of Environment, Food and Rural Affairs. 2006a. UK voluntary reporting scheme for engineered nanoscale materials. London: Defra.Google Scholar
- Department of Environment, Food and Rural Affairs. 2006b. Consultation on a proposed voluntary reporting scheme for engineered nanoscale materials—Consultation questions. London: Defra.Google Scholar
- Department of Environment, Food and Rural Affairs. 2008. The UK voluntary reporting scheme for engineered nanoscale materials: Seventh quarterly report, August. London: Defra.Google Scholar
- Environmental Defense. 2008. Press Release: EPA nanotechnology voluntary program risks becoming a “black hole”, 28 July. New York: Environmental Defense.Google Scholar
- Environmental Defense and DuPont. 2007. Nano risk framework. New York: EDF.Google Scholar
- Environmental Protection Agency. 2008. Notice: nanoscale materials stewardship program. Federal Register 7318: 4861–4866.Google Scholar
- Fleming, N. 2006. Women buying creams made of tiny particles “used as guinea pigs”. The Daily Telegraph. London, 5 May, p.6.Google Scholar
- Gold, J.L., and D.M. Studdert. 2005. Clinical trials registries: a reform that is past due. The Journal of Law, Medicine & Ethics 811–820. (Winter). doi: 10.1111/j.1748-720X.2005.tb00547.x.
- Interessengemeinschaft Detailhandel Schweiz. 2008. Code of conduct for nanotechnologies. Geneva: Swiss Retailer’s Association.Google Scholar
- International Council on Nanotechnology. 2005. Nano coalition unveils environmental, health and safety database. http://www.icon.rice.edu/ (accessed August 19, 2006).
- International Council on Nanotechnology. 2008a. Working groups: Knowledge base team. http://icon.rice.edu/projects.cfm?doc_id=4389 (accessed October 30, 2008).
- International Council on Nanotechnology. 2008b. EHS Database, last updated 23 October. http://cohesion.rice.edu/centersandinst/icon/research.cfm (accessed October 30, 2008).
- Kelsall, D. 2006. Stand and declare: Opportunity and challenge of clinical trial registration. Canadian Family Physician 52: 1189–1190. (October).Google Scholar
- Lemmens, T., and R.A. Rouchard. 2007. Mandatory clinical trial registration: rebuilding public trust in medical research. Global Forum Update on Research for Health 4: 40–46.Google Scholar
- Martinez, B. 2004. Glaxo settles New York suit over unpublished clinical data. The Wall Street Journal 27 August: B3.Google Scholar
- Organisation for Economic Co-operation and Development. 2008. Nanotechnologies at the OECD. Paris: OECD.Google Scholar
- Soil Association. 2006. A proposed voluntary reporting scheme for engineered nanoscale materials. Soil Association response to Defra consultation, July. https://www.soilassociation.org/web/sa/saweb.nsf/b0062cf005bc02c180256a6b003d987f/9e47591b80454944802571b8003c5745?OpenDocument&Highlight=2 (accessed May 5, 2007).
- Standing Committee on State Development. 2008. Nanotechnology in New South Wales. Sydney: NSW Legislative Council.Google Scholar
- Stark, D. 2007. Defra nanotechnology stakeholder meetings, 14 February. http://www.euronanotrade.com/index.php?option=content&task=view&id=557&Itemid=83# (accessed March 6, 2007).
- Stuart, C. 2005. Making labor safety a priority and a profit. Small Times November/December: 32–33.Google Scholar
- US National Institute of Health. 2008. About ClinicalTrials.gov. http://www.clinicaltrial.gov/ct2/info/about (accessed November 2, 2008).
- Woolas, P. 2008. From the Minister for the Environment: UK voluntary reporting scheme for engineered nanoscale materials, 20 March. London: Defra.Google Scholar
- World Health Organization. 2008a. About the WHO ICTPR. http://www.who.ntictrp/about (accessed November 2, 2008).
- World Health Organization. 2008b. International Clinical Trials Registry Platform (ICTRP): Unique identification. http://www.who.int/ictrp/utrn/en/ (accessed November 2, 2008).